Background To compare drug regimens across clinical trials in Parkinson's disease (PD)
conversion formulae between antiparkinsonian drugs have been developed. These are …

Summary 5G has taken off at a brisk speed over the years, bringing significant benefits to the
Internet of Things (IoT) devices and wireless sensor nodes. The launching of 5G technology …

La enfermedad de Parkinson es un trastorno neurodegenerativo complejo y de
presentación heterogénea. Aunque aún no se dispone de ningún fármaco que enlentezca …

Deep brain stimulation (DBS) is a widely used therapy for Parkinson's disease (PD) but
lacks dynamic responsiveness to changing clinical and neural states. Feedback control …

Esta extraordinaria obra ofrece una perspectiva general de la ciencia del desarrollo
humano tan vivaz como lo es la gente en la vida real. Su escritura comunica la emoción y …

Abstract Background and Purpose This update of the treatment guidelines was
commissioned by the European Academy of Neurology and the European section of the …

Abstract Deep Brain Stimulation can improve tremor, bradykinesia, rigidity, and axial
symptoms in patients with Parkinson's disease. Potentially, improving each symptom may …

Although dopamine replacement therapy remains a core component of Parkinson's disease
treatment, the onset of motor fluctuations and dyskinetic movements might require a range of …

Parkinson disease (PD) is the most common neurodegenerative movement disorder. In
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …

Focused ultrasound (FUS) is a disruptive medical technology, and its implementation in the
clinic represents the culmination of decades of research. Lying at the convergence of …